Xiaoping Qian

机构：Nanjing University of Chinese Medicine, National University of Singapore, Xuzhou Medical College, Cancer Institute (WIA), Nanjing Traditional Chinese Medicine Hospital, Nanjing Drum Tower Hospital, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing University · ORCID：0000-0002-5025-5269

发表论文 182 篇 · 总被引 4440 次 · h-index 36

代表论文

• Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells (2023 · International Journal of Nanomedicine · 被引 52)
• c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer (2024 · Cell Death and Disease · 被引 34)
• Extracellular vesicles released by hypoxia‐induced tumor‐associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery (2024 · The FASEB Journal · 被引 17)
• Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases (2023 · Biotechnology and Genetic Engineering Reviews · 被引 14)
• Tactics to Improve the Photodynamic Therapeutic Efficacy Based on Nanomaterials (2025 · Chinese Journal of Chemistry · 被引 13)
• 1524P First-line TST001 plus capecitabine and oxaliplatin (CAPOX) for advanced G/GEJ cancer with CLDN18.2 positive overall survival data from study transtar102-Cohort C (2023 · Annals of Oncology · 被引 6)